0000950170-24-135521.txt : 20241211 0000950170-24-135521.hdr.sgml : 20241211 20241211184406 ACCESSION NUMBER: 0000950170-24-135521 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20241209 FILED AS OF DATE: 20241211 DATE AS OF CHANGE: 20241211 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: KAKKIS EMIL D CENTRAL INDEX KEY: 0001248093 ORGANIZATION NAME: FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36276 FILM NUMBER: 241542692 MAIL ADDRESS: STREET 1: C/O ULTRAGENYX PHARMACEUTICAL INC. STREET 2: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Ultragenyx Pharmaceutical Inc. CENTRAL INDEX KEY: 0001515673 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] ORGANIZATION NAME: 03 Life Sciences IRS NUMBER: 272546083 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 BUSINESS PHONE: 415-483-8800 MAIL ADDRESS: STREET 1: 60 LEVERONI COURT CITY: NOVATO STATE: CA ZIP: 94949 4 1 ownership.xml 4 X0508 4 2024-12-09 0001515673 Ultragenyx Pharmaceutical Inc. RARE 0001248093 KAKKIS EMIL D C/O ULTRAGENYX PHARMACEUTICAL INC. 60 LEVERONI COURT NOVATO CA 94949 true true false false President & CEO true Common Stock 2024-12-09 4 G false 20000 0 D 2203985 I By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 Common Stock 2024-12-10 4 S false 8273 50 D 2195712 I By Emil Kakkis and Jenny Soriano Living Trust, dated June 18, 2009 Common Stock 564605 D Includes previously reported shares of common stock underlying RSUs granted to the Reporting Person, which are subject to certain vesting conditions. Includes 8 shares acquired under the Company's A&R 2014 Employee Stock Purchase Plan on October 31, 2024. /s/ Karah Parschauer, attorney-in-fact 2024-12-11